Biotech Opportunity GP, LLC
- SEC CIK
- 0001816370
No open-market purchases or sales filed in the past year.
Current role at each company
- NUVB Nuvation Bio Inc.Directoras of Sep 22, 2023
- Panacea Acquisition Corp. IIDirector, 10% Owneras of May 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Biotech Opportunity GP, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NUVB Nuvation Bio Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2023 (view filing)3:44 PM ET | Sep 19-21 | 3 days | Nodelman Oleg and 5 othersDirector | PPurchaseClass A Common Stock | +5.31M | $1.26 | +$6.69M | +72.2%12.7M after | Amended3 lots |
| Nov 30, 2021 (view filing)6:07 PM ET | Mar 31-Nov 24 | 244 daysLate | Nodelman Oleg and 5 othersDirector | PPurchaseClass A Common Stock | +393.2K | $8.89 | +$3.49M | +50.7%1.17M after | 4 lots |
| Nov 30, 2021 (view filing)6:07 PM ET | Mar 31 | 244 daysLate | Nodelman Oleg and 5 othersDirector | SSaleClass A Common Stock | +151.5K | $10.45 | +$1.58M | +15.2%1.15M after | |
| Nov 30, 2021 (view filing)6:07 PM ET | Jul 31 | 122 daysLate | Nodelman Oleg and 5 othersDirector | SSaleClass A Common Stock | −56.6K | $8.64 | −$489.0K | −4.7%1.15M after |